Banco Santander SA ADR

Yahoo Finance • 10 hours ago

Santander to sell around a 3.5% stake in Polish unit for $473m

Spanish lender Santander is planning to sell around a 3.5% stake in its Polish subsidiary Santander Polska through an accelerated bookbuild process. This transaction is valued at up to $473m, according to a Reuters report. It follows an... Full story

Yahoo Finance • yesterday

UK lenders clear Bank of England's stress tests

[Street scene in financial district, London] CHUNYIP WONG Large UK banks have cleared the Bank of England's stress tests [https://www.bankofengland.co.uk/financial-stability-in-focus/2025/fsif-the-fpcs-assessment-of-bank-capital-requireme... Full story

Yahoo Finance • 3 days ago

Poland Buy Now Pay Later Business Report 2025: A $2.8 Billion Market by 2030 Featuring Twisto, Klarna, PayPo, Santander, Allegro, mBank, BNP Paribas, ING Bank Slaski, Alior Bank, and Revolut

Company Logo The BNPL market in Poland offers growth opportunities in various sectors like retail, home improvement, travel, and media, supported by a strong consumer base and diverse business models. Key growth areas include the online s... Full story

Yahoo Finance • 5 days ago

Market Voices: Trump on immigration, G20; SEC probing Jefferies

[G20 summit or meeting concept. Row from flags of all members of G20 Group of Twenty and list of countries.] Bet_Noire/iStock via Getty Images _Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, s... Full story

Yahoo Finance • 5 days ago

As Nvidia, Palantir Waver, This Giant Makes Waves On Wall Street

While Google and Apple soar and Nvidia and Palantir struggle, top funds once again bet huge on Banco Santander stock. Continue Reading View Comments... Full story

Yahoo Finance • 6 days ago

Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants

Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants Paris, France, 27 novembre 2025 – Sanofi inaugure aujourd’hui sur son site industriel du Trait, en Normandie, une nouvelle unité qui vient... Full story

Yahoo Finance • 7 days ago

European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

European equities traded in the US as American depositary receipts were surging higher late Wednesda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 7 days ago

Nanotechnology Drug Delivery Market Projected to Reach USD 200.77 Billion by 2032, Owing to Prevalence of Chronic Diseases & Advances in Nanomedicine – SNS Insider

Austin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nanotechnology Drug Delivery Market Size & Growth Analysis According to a SNS Insider, the Nanotechnology Drug Delivery Market size was valued at USD 96.39 billion in 2024 and is projected to re... Full story

Yahoo Finance • 8 days ago

European Equities Traded in the US as American Depositary Receipts Turn Sharply Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were sharply higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 9 days ago

Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compa... Full story

Yahoo Finance • 9 days ago

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé comme étant le premier médicament ciblé dans l’UE depuis plus de dix ans contre l’urticaire chronique spontanée

Dupixent, développé par Sanofi et Regeneron, a été approuvé comme étant le premier médicament ciblé dans l’UE depuis plus de dix ans contre l’urticaire chronique spontanée Approval based on phase 3 studies showing Dupixent significantly r... Full story

Yahoo Finance • 12 days ago

Banks could reap $2.6T from U.S. deregulation, Jefferies says

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Large banks could unlock some $2.6T as a result of U.S. bank deregulation that could drive lending, M&A, and tech investment, Jefferies said in a note to clients on F... Full story

Yahoo Finance • 19 days ago

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes

Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes Recommendation based on the TN-10 study, demonstrating Teizeild’s ability to delay the onset of stage 3 type 1 diabetes (T1D), compared to... Full story

Yahoo Finance • 19 days ago

Communiqué de presse : Teizeild, un médicament Sanofi, a reçu l’approbation du CHMP pour une autorisation de mise sur le marché dans l’UE chez les patients atteints de diabète de type 1 de stade 2

Teizeild, un médicament Sanofi, a reçu l’approbation du CHMP pour une autorisation de mise sur le marché dans l’UE chez les patients atteints de diabète de type 1 de stade 2 La recommandation s’appuie sur l’étude TN-10, qui démontre la ca... Full story

Yahoo Finance • 26 days ago

Has Santander’s 101% Rally Priced In Growth After Green Finance Partnership News?

Wondering whether Banco Santander is truly a good buy, or if its share price is getting ahead of itself? You are not alone, especially with so much buzz around bank stocks lately. The stock has been on a tear, rising 101.0% year-to-date an... Full story

Yahoo Finance • 26 days ago

Top Funds Gobble Up These 4 Stocks — And Nibble On Nvidia, Palantir

While Nvidia, Palantir, Google and Apple earn a spot on the menu, the best mutual funds devour these four stocks. Continue Reading Kommentare anzeigen... Full story

Yahoo Finance • 26 days ago

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase 3 data to be presented at ACAAI demon... Full story

Yahoo Finance • last month

Banco Santander (BME:SAN) Profit Margins Improve, Reinforcing Value Narrative vs. Market Growth Concerns

Banco Santander (BME:SAN) reported net profit margins of 25.3%, an improvement over last year’s 22.9%. Annual earnings grew 19.8% but trailed the five-year average of 36.7% per year. Shares currently trade at €8.75, which is below the esti... Full story

Yahoo Finance • last month

Santander scraps results and calls for Government action on motor finance

Santander UK’s boss has called for Government intervention amid fears over the impact of the motor finance compensation scheme as the lender cancelled third quarter results until it can get “greater clarity” on City watchdog proposals. Th... Full story

Yahoo Finance • last month

Communiqué de presse : Sanofi ancre son futur en France avec un nouveau siège emblématique à Paris La Défense

Sanofi ancre son futur en France avec un nouveau siège emblématique à Paris La Défense Paris, 29 octobre 2025. Sanofi annonce ce jour l’implantation du nouveau siège de ses activités françaises au cœur de Paris La Défense, avec l’ambition... Full story